Human medicines European public assessment report (EPAR): Celdoxome pegylated liposomal, doxorubicin hydrochloride, Date of authorisation: 15/09/2022, Revision: 3, Status: Authorised
Human medicines European public assessment report (EPAR): Celdoxome pegylated liposomal, doxorubicin hydrochloride, Date of authorisation: 15/09/2022, Revision: 3, Status: Authorised